Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States.
Neoplasma. 2022 Jan;69(1):28-35. doi: 10.4149/neo_2021_210511N642. Epub 2021 Nov 25.
We present a retrospective study of 65 cases of solitary fibrous tumors (SFTs) of several localizations including the most common site of origin in the pleura and lungs. SFTs are mesenchymal fibroblastic tumors with an unpredictable biological potential ranging from benign to malignant. We investigated morphologic characteristics, proliferation activity evaluated by immunohistochemical expression of Ki-67 antigen, and the existence of NAB2-STAT6 fusion gene together with Ki-67, TPX2, and TERT mRNA expression levels. The aim was to define relationships between proliferation activity and biological potential and progression of the disease. We measured Ki-67, TPX2, and TERT mRNA levels using quantitative real-time reverse transcription PCR (RQ-RT-PCR). We observed a significant association between increased Ki-67 and TERT mRNA levels and the SFTs with malignant potential. Also, we investigated the effect of TERT promoter mutation on telomerase activation and patient outcome in our SFT cohort. We verified that TERT promoter mutation was frequent (36.6%) and present in a majority of malignant SFTs and SFTs with uncertain biological behavior. TERT promoter mutation alone predicted the disease recurrence.
我们回顾性研究了 65 例孤立性纤维瘤(SFT)病例,这些肿瘤发生于多个部位,包括最常见的起源于胸膜和肺部。SFT 是一种间叶性成纤维细胞肿瘤,其生物学潜能不可预测,从良性到恶性不等。我们研究了形态学特征、Ki-67 抗原免疫组化表达评估的增殖活性,以及 NAB2-STAT6 融合基因的存在,同时还检测了 Ki-67、TPX2 和 TERT mRNA 的表达水平。目的是确定增殖活性与生物学潜能和疾病进展之间的关系。我们使用实时定量逆转录聚合酶链反应(RQ-RT-PCR)测量 Ki-67、TPX2 和 TERT mRNA 水平。我们观察到 Ki-67 和 TERT mRNA 水平的增加与具有恶性潜能的 SFT 之间存在显著关联。此外,我们还研究了 TERT 启动子突变对我们的 SFT 队列中端粒酶激活和患者预后的影响。我们验证了 TERT 启动子突变是频繁的(36.6%),存在于大多数恶性 SFT 和具有不确定生物学行为的 SFT 中。TERT 启动子突变本身可预测疾病复发。